Clinical Trials
4 trialsNCT04572776 2021-11-09
Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
Sorrento Therapeutics, Inc.
Phase 3 Withdrawn
NCT03639415 2021-03-08
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Fujian Cancer Hospital
Phase 4 Withdrawn
NCT01951911 2017-07-11
KETA-1
Haukeland University Hospital
Phase 3 Withdrawn
NCT01687751 2015-05-25
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
Phase 2 Withdrawn